Skip to Content
MilliporeSigma
All Photos(1)

Documents

1604803

USP

Ritonavir

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C37H48N6O5S2
CAS Number:
Molecular Weight:
720.94
UNSPSC Code:
41116107
NACRES:
NA.24

biological source

synthetic

grade

pharmaceutical primary standard

agency

USP

vapor pressure

<0.0000001 kPa ( 25 °C)

API family

ritonavir

form

powder

packaging

pkg of 200 mg

manufacturer/tradename

USP

storage condition

protect from light

color

white to tan

solubility

acetonitrile: slightly soluble
ethanol: freely soluble
methanol: freely soluble
methylene chloride: freely soluble
water: practically insoluble

application(s)

pharmaceutical (small molecule)

format

neat

InChI

1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1

InChI key

NCDNCNXCDXHOMX-XGKFQTDJSA-N

Looking for similar products? Visit Product Comparison Guide

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.

Application

Ritonavir USP reference standard suitable for use in specified USP compendial tests and assays.

Also used to prepare standard, standard stock, identification, and standard working solution for assay, impurity analysis, and performance test according to the given below monographs of United States Pharmacopeia (USP):
  • Lopinavir and Ritonavir Tablets
  • Ritonavir Tablets
  • Ritonavir
  • Lopinavir and Ritonavir Oral Solution

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 9

1 of 9

vibrant-m

BP1210

Ritonavir

Lopinavir &#8805;98% (HPLC)

Sigma-Aldrich

SML1222

Lopinavir

Eshmuno&#174; P Resin Eshmuno&#174; P anti-A, 50&#160;&#956;m mean particle size

Millipore

1.20094

Eshmuno® P Resin

USP

USP

1339178

Indinavir

Chloroquine phosphate United States Pharmacopeia (USP) Reference Standard

USP

1118000

Chloroquine phosphate

Darunavir &#8805;98% (HPLC)

Sigma-Aldrich

SML0937

Darunavir

Efavirenz United States Pharmacopeia (USP) Reference Standard

USP

1234103

Efavirenz

vibrant-m

Y0002055

Fingolimod hydrochloride

Chloroquine phosphate Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1258

Chloroquine phosphate

Ritonavir
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 37(4), 3912-3912 (2020)
Lopinavir and Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 2670-2670 (2013)
Ritonavir Tablets
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 3920-3920 (2013)
Lopinavir and Ritonavir Oral Solution
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4), 2666-2666 (2015)
RP-HPLC method development and validation for simultaneous estimation of Lopinavir and Ritonavir in tablet dosage form
Bindu MJ, et al.
International Journal of Science and Engineering Applications, 5(1), 77-77 (2017)

Related Content

This application note illustrates how it is possible to set-up an assay method for Lopinavir and Ritonavir tablets.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service